Optune
Tumor Treating Fields therapy that uses electric fields to disrupt cancer cells in GBM.
Optune delivers Tumor Treating Fields (TTFields) therapy, a treatment that uses electric fields to disrupt cancer cells, offered as an option for GBM. For patients researching what else can be done, it represents a different kind of mechanism: attacking tumor cells with fields rather than with drugs alone, within the electric fields and thermotherapy category.
- FDA status · FDA-approved device
- Indication · Adults 22 and older with newly diagnosed or recurrent glioblastoma (GBM)
- Manufacturer · Novocure
Ask anything about Optune
How Optune works
Training before use
Optune Gio is used only after training from qualified personnel who have completed a Novocure training course.
Arrays are applied to the scalp
Adhesive arrays with conductive hydrogel, similar to EKG electrodes, connect to a portable device that creates Tumor Treating Fields.
Wear and maintain the device
Arrays are changed at least twice per week and no less than once every 4 days. Daily usage is tracked in the MyNovocure app.
Ongoing support
Support covers supply ordering, troubleshooting, and treatment reminders.
Who it's for
Not sure it fits your case? Ask above and get an answer in seconds.
What Optune offers
- Tumor Treating Fields for GBM
- Disrupt the cancer cells
Get started with Optune
What it costs
Optune hasn't shared insurance details with us yet. Check what your plan covers, or ask Optune when you connect.
Understand this before you decide
Get guidance specific to your case
This page is general information. Add your records and we tailor answers to your diagnosis.

